Video: Inspiring Story – ifarmwell
Philanthropy Australia
Mon, 26 Aug 2024
Designed by Australian farmers, ifarmwell helps other Australian farmers cope effectively with life’s challenges and get the most out of every day.
Read more
Video: Inspiring Story – Foundation Barossa
Philanthropy Australia
Mon, 26 Aug 2024
Foundation Barossa nurtures and builds its community’s strength and assets, responding to challenges and opportunities and supporting organisations and individuals to do likewise.
Watch: Inspiring video stories of South Australia
Philanthropy Australia
Fri, 23 Aug 2024
The Philanthropy Australia Conference 2024, hosted in Adelaide, SA on Kaurna Country, showcased six inspiring stories of purpose from South Australia.
‘This will improve the lives of kids with cancer globally’ – medical research gets $155.5m boost in one week
Philanthropy Australia
Fri, 23 Aug 2024
Two incredible medical research gifts were announced this week, giving a combined boost of more than $150m to the field, particularly in cancer treatments for children. The Stan Perron Charitable Foundation in Western Australia has pledged $135.5m to the Telethon Kids Institute Cancer Centre and Perth Children’s Hospital. A $20 million bequest in NSW by the philanthropist Kay Van Norton Poche will give Australians the same access to clinical trials as patients in the US.
Staying the course for generational change with Children’s Ground
English Family Foundation
Fri, 31 May 2024
Children’s Ground is designed to change the status quo – led by First Nations people and the oldest knowledge systems in the world to achieve radical reform for First Nations children over a 25-year period.
How impact investment is making a difference in global health equity
Mark Sullivan AO, founder and managing director of Medicines Development for Global Health
Fri, 2 Feb 2024
Impact investing is playing a critical and growing role in the development of medicines to treat ‘neglected diseases’ affecting the world’s poorest and most underserved peoples. These medicines would not otherwise be developed by the pharmaceutical industry, which is primarily driven by financial returns. Here, Mark Sullivan AO, founder and managing director of Medicines Development for Global Health, an Australian biopharmaceutical not-for-profit, describes how this finance model is supporting the development of Moxidectin – a potential gamechanger for the WHO’s roadmap to ending river blindness by 2030.
